pDONR223_KRAS_p.G12C Citations (1)

Originally described in: Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.
Kim E, Ilic N, Shrestha Y, Zou L, Kamburov A, Zhu C, Yang X, Lubonja R, Tran N, Nguyen C, Lawrence MS, Piccioni F, Bagul M, Doench JG, Chouinard CR, Wu X, Hogstrom L, Natoli T, Tamayo P, Horn H, Corsello SM, Lage K, Root DE, Subramanian A, Golub TR, Getz G, Boehm JS, Hahn WC Cancer Discov. 2016 Jul;6(7):714-26. doi: 10.1158/2159-8290.CD-16-0160. Epub 2016 May 4. PubMed Journal

---

Articles Citing pDONR223_KRAS_p.G12C

Articles
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers. Rubinson DA, Tanaka N, Fece de la Cruz F, Kapner KS, Rosenthal MH, Norden BL, Barnes H, Ehnstrom S, Morales-Giron AA, Brais LK, Lemke CT, Aguirre AJ, Corcoran RB. Cancer Discov. 2024 Jan 18. doi: 10.1158/2159-8290.CD-23-1138. PubMed

If you have published an article using this material, please email us at to have your article added to this page.